Ward: Environment

208

4 reasons Americans aren’t drinking as much alcohol this holiday season — or any at all

The growing use of weight-loss drugs is one factor behind the decline in alcohol consumption.

131

Fewer people would recommend MMR vaccine: Survey

As measles cases continue to spread across the country, a survey released Monday shows a “small but significant drop” in the proportion of the public that would recommend someone in their household get the measles, mumps and rubella (MMR) vaccine. According to the poll from the Annenberg Public Pol…

209

Sitting by a window may improve blood sugar levels for type 2 diabetes

Our cells follow 24-hour circadian rhythms that regulate our blood sugar levels and are heavily influenced by light exposure. Scientists have harnessed this to show that just sitting by a window improves blood sugar control in people with type 2 diabetes

232

4 reasons Americans aren’t drinking as much alcohol this holiday season — or any at all

Fewer people would recommend MMR vaccine: Survey

Sitting by a window may improve blood sugar levels for type 2 diabetes

Tattooing may trigger localised damage to the immune system

Your period may make sport injuries more severe

The US beat back bird flu in 2025 – but the battle isn’t over

Human challenge trials have never been more popular

FDA approves Wegovy pill, the first prescription pill for weight loss

Former GOP Sen. Ben Sasse says he has terminal stage-four pancreatic cancer

FDA approves Wegovy pill for weight loss

Flu season is ramping up, and some experts are "pretty worried"

STAT+: The best and worst drug names this year

Study revives debate about unpopular diet for cancer patients

STAT+: We’re reading about new TrumpRx deals, Samsung Biologics’ first U.S. plant, and more

An advocate who offered a window on the experience of living with brain cancer dies at 43

STAT+: We’re reading about the first approved GLP-1 pill, deal-hungry Ipsen, and more

Opinion: 4 questions to understand the costs of ‘medical freedom’

STAT+: FDA flashpoints to watch next year

How testosterone fell out of favor in medicine — and how it came back

FDA approves pill version of Novo Nordisk’s Wegovy, possibly widening access